Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More

The University of Edinburgh has perfected a genetic engineering strategy in mouse embryonic stem cells to replace large regions of mouse chromosomal sequences (>100kb) with the corresponding human syntenic region. More

This invention relates to a cell based therapy; specifically, the isolation and enrichment of stem cells from adult tendons that can form tendon structures and are capable of integrating into bones to form enthesis-like structures. More